Nicholas Lacivita
Psychiatry · Brandon, MSNPI 1700451291
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 139 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Teva Pharmaceuticals USA, Inc. at 24.6% of the total. Reporting peaked in 2024 at $1,859 and has fallen 59.4% since, to $754 in 2025.
Across 139 payments — averaging $31.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$1K
- Alkermes, Inc.$700
- Johnson & Johnson$440
- Neurocrine Biosciences, Inc.$417
- Lundbeck LLC$406
- E.r. Squibb & Sons, L.L.C.$327
- plus $996 from 8 others
What the payments were for
- Food & beverage$4,362100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 33 | $1,075 |
| Alkermes, Inc. | 17 | $700 |
| Johnson & Johnson | 17 | $440 |
| Neurocrine Biosciences, Inc. | 14 | $417 |
| Lundbeck LLC | 19 | $406 |
| E.r. Squibb & Sons, L.L.C. | 8 | $327 |
| Otsuka America Pharmaceutical, Inc. | 8 | $266 |
| Avanir Pharmaceuticals, Inc. | 7 | $201 |
| AbbVie | 8 | $186 |
| Vanda Pharmaceuticals Inc. | 3 | $112 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $102 |
| Bioxcel Therapeutics, Inc. | 1 | $97 |
| Stryker | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$972
- ARISTADA$473
- INGREZZA$133
- REXULTI$125
- NUEDEXTA$125
- UZEDY$122
- ARISTADA INITIO$118
- COBENFY$113
- Austedo XR$105
How this compares
$4,362 in reported general payments places this provider in the 85th percentile of 219 psychiatry providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 19 | $162,257 |
| Invega SustennaPaliperidone Palmitate | 19 | $48,409 |
| AristadaAripiprazole Lauroxil | 14 | $44,217 |
| VraylarCariprazine Hcl | 16 | $24,939 |
| TrintellixVortioxetine Hydrobromide | 12 | $7,147 |
| Chlorpromazine Hcl | 23 | $2,494 |
| Haloperidol Decanoate | 33 | $1,507 |
| Lurasidone Hcl | 18 | $1,396 |
| Atomoxetine Hcl | 12 | $701 |
| Duloxetine Hcl | 28 | $522 |
| Divalproex Sodium | 25 | $434 |
| Bupropion XlBupropion Hcl | 14 | $360 |
| Quetiapine Fumarate | 24 | $346 |
| Hydroxyzine Pamoate | 27 | $301 |
| Aripiprazole | 20 | $287 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $417 | $162,25719 claims |
| Johnson & JohnsonInvega Sustenna | $440 | $48,40919 claims |
| Alkermes, Inc.Aristada | $700 | $44,21714 claims |
| AbbVieVraylar | $186 | $24,93916 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 219 psychiatry providers in Mississippi.
Other psychiatry in Brandon
- Maxie GordonClinton$1.3M
- Kurt BuechlerRidgeland$1.1M
- Chasity TorrenceWhitfield$834K
- Jon JacksonJackson$834K
- John NortonJackson$173K
- Amy MillerSaltillo$82K
- Clyde GlennRidgeland$68K
- Krishan GuptaJackson$26K
- Joseph KwentusFlowood$13K
- Mark WebbRidgeland$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.